Sanofi Expands Consumer Health Reach With Minsheng VMS Joint Venture
This article was originally published in The Tan Sheet
Executive Summary
A joint venture with Minsheng Pharmaceutical Group brings Sanofi-Aventis one step closer to its goal of doubling its consumer health care business in five years and opens a powerful distribution channel in China through which the French firm can market newly acquired supplements
You may also be interested in...
Sanofi's Consumer Division Cushions Blow From Rx Exclusivity Losses
Sanofi-Aventis' expanding consumer health division is a shining beacon for growth even as the pharma giant plunges off a prescription drug patent cliff.
Sanofi's Consumer Division Cushions Blow From Rx Exclusivity Losses
Sanofi-Aventis' expanding consumer health division is a shining beacon for growth even as the pharma giant plunges off a prescription drug patent cliff.
Sanofi's Consumer Division Cushions Blow From Rx Exclusivity Losses
Sanofi-Aventis' expanding consumer health division is a shining beacon for growth even as the pharma giant plunges off a prescription drug patent cliff.